As many in the United States pause to commemorate Independence Day – and, hopefully, re-commit to the fundamental principles of democracy – the global health community continues to navigate the far-reaching effects of US policy decisions. Institutions are changing, governance is being redefined and the systems that have underpinned the global HIV response are being reshaped. This issue covers developments in global health governance, the continued restructuring of US vaccine policy and growing concerns that PEPFAR’s transition is outpacing the systems needed to sustain it.

Global Governance Shifts

The last two weeks, and the week ahead, mark key moments for global health governance with implications for the HIV response. Last week, for the first time in 25 years, UN Member States adopted a new Political Declaration on HIV/AIDS with a vote (with the US voting no), as opposed to the historic consensus of all past declarations. This week, both the UNAIDS Programme Coordinating Board (PCB) and the Unitaid Executive Board met against the backdrop of financial strain and uncertainty. Conversations and debates about their future roles continued, including questions about UNAIDS’ future structure within the UN system. Next week, the Global Fund Board will meet as it prepares to select its next Executive Director who is expected to shape the Fund’s strategic direction during one of the most challenging periods in its history.

IMPLICATIONS: In all these meetings, there is a reassessment of each entity and a reenvisioning of how global health organizations will coordinate, finance and sustain the HIV response in an era of constrained resources and shifting geopolitical priorities. As countries work toward the 2030 goal of ending AIDS as a public health threat, the decisions made by these governing bodies in the coming weeks will help determine whether and how the HIV response maintains the leadership, financing, accountability, collaboration and civil society engagement needed to carry the response forward.

READ:

• Does the UN Political Declaration on HIV/ AIDS Even Matter Anymore?—Lights. Camera. Equity! Substack  
• Merger, hub, or slimmer secretariat? What’s next for UNAIDS—Devex  
• Candidates Shortlisted In Contentious Global Fund Leadership Race—Health Policy Watch 
• From innovation to impact: Building on 20 years of progress—Unitaid  

US HHS Rewrites ACIP Charter, Further Reshaping US Vaccine Policy

The US Department of Health and Human Services (HHS) issued a new charter for the CDC’s Advisory Committee on Immunization Practices (ACIP), broadening the Committee’s mandate and reducing the qualifications required for membership. Previously, vaccine expertise was a requirement, but the revised charter states that members should collectively represent a “balanced range of scientific, clinical, and public health expertise”. The new charter also expands the Committee’s focus beyond reviewing vaccines to considering alternative approaches to disease prevention.

IMPLICATIONS: This is the latest step in the restructuring of ACIP. By broadening the Committee’s remit and redefining membership qualifications, vaccine policymaking is further politicized and vaccine confidence continues to erode. This creates further instability and uncertainty for vaccine manufacturers, healthcare providers and immunization programs worldwide.

READ:

• New ACIP charter could allow RFK Jr. to further restrict vaccine access, critics say—CIDRAP  
• Inside the C.D.C.’s Mad Scramble to Meet Kennedy’s Demands—New York Times 
• Sanders releases trove of internal HHS emails showing RFK Jr. pressured CDC over vaccine messaging—The Hill 
• RFK Jr Changes Terms for US Vaccine Committee as Email Leak Reveals Sustained Political Interference in Vaccine Policy—Health Policy Watch 

PEPFAR In Transition

Two commentaries this week recognize the breaking point to which PEPFAR is nearing. The Health Security Policy Academy argues that despite the temporary extensions, which have kept and continue to keep parts of PEPFAR operating, the US Department of State has not yet built a viable implementation system to keep HIV treatment, supply chains, laboratories and community programs working. At the same time, Emily Bass, Yvette Raphael, Nono Eland and colleagues at Physicians for Human Rights argue in Think Global Health that the planned phase-out of all US PEPFAR support for South Africa by early 2027 is not a routine transition to country ownership, and caution that this accelerated withdrawal risks severed disruption to HIV prevention, surveillance, research and community programs that have long depended on US partnership.

IMPLICATIONS: Without a clear implementation strategy and carefully managed country transitions, these abrupt changes to PEPFAR threaten essential HIV services. A more deliberate, evidence-based approach that preserves critical infrastructure while supporting long-term country ownership is needed. “The dismantling of USAID showed what happens when the Administration destroys an operating system before a replacement exists. That chaos was not an accident, but it was sudden,” writes the Health Security Policy Academy. It remains even less clear what happens next with leadership transitions at the State Department: Jeremy Lewin who has led the State Department’s foreign aid bureau for the last year is heading to the National Security Council, and is being replaced by Andrew Veprek, who has pushed immigration and refugee restrictions at the State Department – and confirmation hearings are yet to be scheduled for Johnny Figueroa as the ambassador-at-large for global health security and diplomacy and PEPFAR.

READ:

• The CDC PEPFAR Shutdown Is Hiding in Plain Sight—Health Security Policy Academy 
• United States Pulls Funding for South Africa, Threatening HIV Defenses—Think Global Health  
• Human impact of cuts to global aid in South Africa—The Lancet HIV  
• State Department’s foreign aid chief heads to the White House—Devex 
• Immigration hardliner takes over US foreign aid—Devex  
• U.S.A.I.D. Cuts Killed People. That’s the Truth.—New York Times 

What We’re Reading

• NIH Budget Cuts Threaten HIV Research—Think Global Health 
• The war against ‘woke’ could end US science as we know it—The Verge 
• NIH likely to award fewer grants as it races to spend 2026 budget—Science  
• Inside the new political screening that’s stalling NIH grants—Nature  
• US to give Tanzania $1.3 billion under five-year health pact—Reuters 
• Tanzania, US sign Sh8 trillion health partnership to strengthen health systems—The Citizen  
• Quiet regulation changes could censor vital research—The Boston Globe 
• 3 questions about the future of US foreign aid—Devex Pro Insider 
• Exclusive: Democrats push Trump to coordinate with WHO on Ebola—Semafor  
• US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests—The Guardian  
• Zim Intensifies HIV Prevention Drive as Lenacapavir Gains Momentum—The Herald 
• Anthropic releases Claude Science, a product aimed at researchers, the pharma industry—STAT  
• Pileup of health nominees awaits Senate health panel—Axios
• Global Fund Approves Emergency Funding to Maintain TB and HIV Services in Crisis-Affected Lebanon and Iraq—The Global Fund 
• Military Leaders Sought Flu Vaccination Program Weeks Before Outbreak Hit Base—New York Times 
• Attacks on Science: A Methodology for Tracking and Identifying Threats to Science in the Federal Government—Union of Concerned Scientists 

Global health is being reshaped by rapid geopolitical shifts, scientific breakthroughs and the growing role of artificial intelligence — creating both new opportunities and new challenges. Translating scientific breakthroughs into impact requires protecting research, advancing equitable access and ensuring communities are at the center. Explore AVAC’s latest resources to help navigate and shape what comes next.

Think Global Health: NIH Budget Cuts Threaten HIV Research

AVAC’s Stacey Hannah and Mitchell Warren remind us in Think Global Health that “at a moment when scientific progress is advancing, advocates, researchers, policymakers, and communities should push back against politically motivated, fringe, antivaccine sentiments that threaten decades of investment to develop the tool that would finally break the back of the epidemic.” 

From Anticipation to Action: The Civil Society Advocates’ Checklist for Lenacapavir for PrEP 

The introduction of injectable lenacapavir for HIV PrEP (LEN) is underway–in some places at least. To ensure communities remain at the center of LEN rollout, this new Advocates’ Checklist for Lenacapavir for PrEP Introduction is an immediate, actionable blueprint designed to help civil society organizations (CSOs) and global health advocates pressure-test government commitments, map implementation bottlenecks and demand equitable access. The checklist is designed to support faster, community-centered rollout ahead of broader generic availability in 2027, as described by the co-chairs of the Civil Society Caucus of the Coalition to Accelerate Access to Long-Acting PrEP and AVAC staff.

The Future Won’t Build Itself: Sustaining the Movement CASPR Started

Tuesday, 14 July @ 9:00am EDT  16:00 EAT 

Join AVAC and partners to hear the impact stories of ten years of the Coalition to Accelerate and Support Prevention Research (CASPR). Established in 2016, CASPR was funded by the United States Agency for International Development (USAID) and designed by AVAC with leading civil society partners to influence HIV prevention research, policy and implementation. With attacks on global health and shrinking resources dismantling hard-won gains, the lessons from CASPR are a call for continued action: strong, community-led advocacy is indispensable to safeguard the future of HIV prevention.

Community First: Practical Strategies for Inclusive Implementation Science

Wednesday, 15 July @ 11:00am EDT  18:00 EAT 

Join The Choice Agenda and Hunter College’s Sarit Golub for a participatory discussion on implementation science – including opportunities, pitfalls and ways in which community leadership is essential to success. What are the different types of implementation science, and how do we move forward with community and front-line implementers at the helm? 

AI & HIV Newsletter

ICYMI, AVAC launched the AI & HIV Newsletter, a new quarterly resource highlighting the latest tools, research, policy developments and news at the intersection of AI and HIV. Designed for advocates and the global community and guided by an expert advisory board, the newsletter provides readers with the information and resources to engage with AI in ways that strengthen equity, protect individuals and communities and prioritize their inclusion, and ensure that technological innovation advances the HIV response. 

The pace of change in global health is not slowing and neither is the need for informed, coordinated advocacy. Look out for our AIDS 2026 conference roadmap and more resources coming soon! 

UN member states and agencies will meet next week, June 22 and 23 for the 2026 UN High-Level Meeting on HIV/AIDS (HLM) with the goal of charting a path toward ending AIDS as a public health threat by 2030. HLMs on HIV/AIDS have been held every five years since 2001—the meeting that energized the HIV/AIDS response and led to the creation of the Global Fund and PEPFAR. However, this year’s meeting arrives at a time of shrinking HIV budgets, disruptions to prevention and treatment programs, under investment, and questions about the future of multilateral cooperation.

See the new UNAIDS report published last week, which shows that external funding cuts, a strong push back on human rights and under investment and under prioritization of HIV prevention and community services are threatening to reverse years of gains in the AIDS response. UNAIDS also has resources for the HLM here. Read more below for what’s at stake and how to engage in the process.

The HLM will test whether governments are prepared to match innovation with the political commitment, financing, human rights protections and community leadership needed to continue moving forward. With or without a declaration, the HIV movement must continue pushing forward based on the scientific evidence and human rights.

What To Watch

At the center of the meeting is a political declaration to guide the global HIV response for the next five years. Civil society organizations outlined a range of priorities in the lead-up to the HLM, and negotiations on this declaration have already become contentious. Advocates and many delegations raised concerns about efforts to weaken commitments on key populations, human rights, community leadership, access to medicines, financing, and discriminatory laws.

All eyes will be on New York next week as country delegations, advocates, policymakers and journalists monitor the negotiations. Stay tuned for more: AVAC will summarize the latest developments in our weekly Global Health Watch newsletter.

Why the HLM Matters

As AVAC’s Mitchell Warren told Global Dispatches podcast, “[Progress] all stems from shared strategy that these high-level meetings and that the multilateral system have codified… this high-level meeting is not just a check-in on progress and a forward-looking strategic declaration. It’s a test of the concept. It is a test of the will of political leaders and of civil society. Are we still in a global discourse about ending an epidemic? Or are we closing borders and shutting down and leaving every country and every community to do it themselves? Because if we are, the end of this epidemic is going to be pushed out many, many years. And that’s the test of concept ahead of us.”

In New York? Join Us

Delivering the HIV Prevention Ambition: Partnership, Country and Community Leadership, and Shared Accountability
Monday, June 22, 2026; 1:15-2:30pm EDT
On the sidelines of the HLM, AVAC will join UNAIDS, UNFPA and the Global HIV Prevention Coalition for a discussion on how to achieve the global 40+20 prevention targets to reach 20 million people with prevention services by 2030.

Accelerating Progress Towards Ending HIV, TB, Hepatitis and STIs New Approaches to End Major Epidemics
Monday, June 22, 2026; 1:15-2:30pm EDT
The WHO and UN Member States will convene partners for an HLM side event focused on accelerating progress against HIV, TB, viral hepatitis and STIs. During this event, AVAC and partners will explore new approaches to sustain gains, address persistent inequalities and advance the global effort to end these major epidemics.

Future-Proofing the AIDS Response: Harnessing the Power of Innovation and Communities
Tuesday, June 23, 2026; 8:00-9:30am EDT
The UNDP, UNFPA, WHO, UNODC, UNICEF, UN Women, UNHCR — in collaboration with GNP+, AVAC, women’s organizations, and key population networks — will bring UN organizations and civil society partners together to discuss the role of communities in advancing the AIDS response.

The HLM will test whether governments are prepared to match innovation with the political commitment, financing, human rights protections and community leadership needed to continue moving forward. With or without a declaration, the HIV movement must continue pushing forward based on the scientific evidence and human rights. 

The US Administration names a nominee to lead US global health diplomacy at the State Department, and NIAID ushers in new interim leadership, just as scientists warn that political interference is increasingly threatening the institutions that drive federally funded research and innovation. From the updated Bethesda Declaration and controversy at the American Diabetes Association annual meeting, to high-stakes negotiations on the UN Political Declaration on HIV/AIDS ahead of the upcoming High-Level Meeting, the politicization of science and public health are on full display this week.

State of Negotiations Ahead of UN High-Level Meeting on HIV/AIDS

Negotiations on the political declaration have intensified this week, as the June 22-23 UN High-Level Meeting on HIV/AIDS inches closer. With a third-round draft due June 15, many advocates and delegations question whether consensus can be secured around diluted provisions on key populations, discriminatory laws, community leadership, human rights, and access to medicines. These differing positions by state and non-state actors could ultimately result in a vote on the declaration rather than adopting it by consensus. Advocates report that the text would replace commitments to repeal discriminatory laws with softer language encouraging countries to “review and change as appropriate”, while references to community-led responses and key populations have been weakened or removed in multiple sections. Financing is also a major point of contention, with advocates challenging the proposed $20.6 billion annual HIV financing target and the absence of language addressing official development assistance (ODA) despite calls from many countries.

IMPLICATIONS: The negotiations come as the recent PEPFAR data and new analyses from the Clinton Health Access Initiative (CHAI) indicate continuing declines in HIV prevention implementation and service delivery. Advocates warn that a watered-down declaration could legitimize national government backsliding on human rights, community leadership, access to medicines and financing at the moment when concrete political commitments on the key provisions are most needed to make progress on international goals against the HIV epidemic. UN delegations and civil society are further debating whether no commitments on the current iteration of the declaration may be more advantageous and acceptable than a version that undermines human rights. In the final two weeks of negotiations, advocates are urgently encouraging partners to push their governments to have stronger human rights and key population language in the declaration.

READ:

• RAPID ACTION ALERT: The U.N. Political Declaration On HIV Is Being Undermined—Health Gap
• Plunging HIV Budgets Cast Dark Shadow Over UN High-Level Meeting—Health Policy Watch
• Scientific Breakthroughs and Political Retreat Set the Stage for a Crucial Global Moment in the Fight Against HIV/AIDS—Global Dispatch

House Advances HHS Funding Bill with Major HIV, Public Health and Research Implications

The House Appropriations Committee this week voted to advance its Fiscal Year 2027 Labor, Health and Human Services (LHHS) funding bill, which would reduce HHS funding by approximately 4 percent, from $116.6 billion to $110.8 billion. The proposal includes significant reductions to public health programs, including $1 billion in cuts to the Centers for Disease Control and Prevention (CDC), much of it affecting HIV-related activities. During the markup, lawmakers approved a bipartisan amendment expressing concern over delays in National Institutes of Health (NIH) grant announcements and noting that available NIH grant funding is nearly 50 percent lower in FY2026 than it was in FY2024. The committee rejected amendments that would have blocked a proposed Office of Management and Budget (OMB) rule expanding political influence over federal grantmaking and protected NIH researchers from dismissal for political reasons.

IMPLICATIONS: The markup of this bill reflects a continued shift in US research and science policy toward reduced federal investment in public health and greater political oversight of research and grantmaking. For the HIV field, the proposed cuts to CDC HIV activities come as the Administration promotes new prevention technologies and seeks to reshape PEPFAR and broader public health programs, raising concerns about the future capacity to deliver prevention, surveillance and implementation programs. At the same time, congressional concern over NIH grant delays underscores growing anxiety about the state of US biomedical research. The bill still has many steps to go in the legislative process before it becomes law, but it highlights significant headwinds for global health and research.

• How cuts to CDC are dismantling its capacity to protect Americans’ health—The Conversation
• Trump administration has its sights set on destroying international research collaborations—BMJ

Scientists Issue Bethesda Declaration: One Year Later

Nearly 40 former and current staff at the National Institutes of Health (NIH) authored a new report, The Bethesda Declaration One Year Later, Continuing Harms to the NIH Mission, which outlines nine deepening concerns at the NIH over the last year along with proposed solutions. This report comes one year after hundreds of NIH employees accused the Administration of politicizing biomedical research through the original Bethesda Declaration. The new report notes that the Administration is slowing medical research, disrupting international collaborations, weakening ethical safeguards, driving away experienced staff and undermining public trust in science. Approximately 24% fewer NIH research projects were funded in 2025 than in 2024 and more than 5,500 peer-reviewed grants were terminated. The report also warns that the White House’s proposed Office of Management and Budget (OMB) rule, which would subject federal grants to greater political review and require alignment with presidential priorities, would institutionalize many of the changes researchers have opposed in the last year.

IMPLICATIONS: The updated Bethesda Declaration shows growing concern from the scientific community about the politicization of science. The NIH has served as the foundation of HIV research, from supporting basic science, vaccine development, implementation of new prevention technologies and global research partnerships. As political oversight expands and international collaboration is deconstructed, the US risks undermining the scientific infrastructure that has fueled decades of innovation and partnership.

• NIH’s destruction continues, Bethesda Declaration signers say—Science
• NIH Scientists Issue ‘Bethesda Declaration’ to Protest Research Politicization—The Scientist
• The Bethesda Declaration: A Call for NIH and HHS Leadership to Deliver on Promises of Academic Freedom and Scientific Excellence—Stand Up For Science
• ‘A deliberate crippling’: NIH researchers, Mass. scientists sound alarm over new funding rules—Boston Globe
• The Bethesda Declaration: One Year Later. Continuing Harms to the NIH Mission—27UNIHTED
• NIH staffers published a letter of dissent a year ago. They feel it’s been ignored—STAT

Scientific Societies Face Pressure as Politicization of Science Intensifies

Several prominent diabetes researchers were removed from the American Diabetes Association (ADA) annual scientific meeting for distributing paper copies of an editorial (published in the Association’s own journal) that criticized the Trump administration’s attacks on research, funding and academic freedom. The incident sparked widespread backlash across the scientific community, with thousands of researchers signing an open letter condemning the ADA’s actions as a failure to defend scientific independence and free expression. The chief executive of the ADA issued a public apology for removing researchers from the conference noting that the ADA is commissioning an independent review of the incident.

IMPLICATIONS: Scientific progress has traditionally depended on peer review, open debate, international collaboration and the ability of researchers to challenge policy decisions without fear of retaliation. This event comes amid broader concerns about the Administration’s proposed OMB rule that would significantly expand political oversight of federal research grants. Scientific independence is moving beyond funding cuts and into control of scientific inquiry. This shift will have lasting consequences for HIV prevention, vaccine development, outbreak preparedness and broader research.

READ:

• Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts—STAT
• Diabetes society apologizes after removal of Trump protesters from conference sparks outrage—Science
• Police Remove Diabetes Experts from Conference For Distributing Critique of Trump Administration—New York Times

Take Action: Proposed White House Regulation Politicizes Federal Research Funding 

There are a series of ways you can take action to oppose the White House Office of Management and Budget (OMB)’s proposed sweeping new regulations to significantly expand political interference in federal research funding decisions across all federal grants. 

• Webinar: Your Comment Counts: Challenging the OMB Proposal Threatening Federal Grant Recipients 
• Contact your legislators: Urge the White House to withdraw the proposed OMB grant review rule 

What We’re Reading

• The Trump administration’s long-awaited global health nomination—Devex
• NIAID appoints new acting director after weekslong questions over leadership—STAT
• CHAI reports impact of cuts in HIV, CD4 and viral load testing, reduced PrEP: children fare worst—HIVi-base
• ‘It’s like we just dumped them’—The Continent
• In his book, self-described USAID ‘whistleblower’ talks about the agency and Ebola—NPR
• Analysis of US and Global Fund Funding Reductions in MOU Countries—KFF
• HPV vaccines allow nations, states to set deadline for eliminating cervical cancer—CIDRAP
• Is the US prepared for the next pandemic? How Trump’s policies have weakened defenses—Bloomberg
• HIV Cure Research: Momentum, Community and What’s Next—AVAC
• ‘ … they just take one pill, so it is easy to use, more convenient … ’: South African health care provider perspectives on a Dual Prevention Pill—Journal of Social Aspects of HIV
• One protestor killed in Kenya protests over Ebola quarantine for Americans—NBC News
• Lenacapavir in South Africa: A Milestone Worth Celebrating, and a Reminder of the Work Ahead—African Women Prevention Community Accountability Board

HIV cure research is making meaningful strides toward strategies that could transform the future of HIV care, as news that immune-based therapies and broadly neutralizing antibodies may one day make long-term HIV remission achievable without daily treatment.

As scientific progress accelerates, AVAC’s cure programs are ensuring communities remain at the center of the agenda. Through initiatives like the US HIV Cure Academy, global advocacy convenings and community-led storytelling, AVAC is equipping advocates with the knowledge and networks needed to shape the future of HIV cure research and bridge the gap between complex science and the communities most impacted by HIV. Read on for exciting updates and AVAC’s involvement in HIV cure research.

The 2026 US Cure Academy: Where science and community meet

The 2026 US HIV Cure Academy brought together 20 advocates and 11 researchers and cure experts from across the US for three days of shared learning, collaboration and hope in Durham, North Carolina. Hosted by AVAC, The Well Project and the Martin Delaney Collaboratories, the Academy equipped participants with the latest updates in HIV cure research while strengthening their ability to translate complex science into meaningful community engagement and advocacy.

Through candid dialogue, hands-on learning and lasting connections, the Academy highlighted the essential role of community partnerships in advancing ethical, inclusive and people-centered HIV cure research. The US Cure Academy series started in 2025 and is meant to continue annually, to build a strong cadre of advocates to help guide cure research according to community priorities.

AVAC also partners with the International AIDS Society (IAS) on the Advocacy-For-Cure Academy international program that prepares the next generation of cure advocates globally to fight effectively for research that matters to the people who are most impacted by HIV.

VIDEO: Hear from Academy participants!

BeCURE Brings HIV Cure Research Closer to Community

AVAC’s Jessica Salzwedel spoke about person-centered care at KURE — an event that brought community and researchers together in Germany — ahead of the opening of the Berlin Center for HIV Cure (BeCURE). Building on Berlin’s unique legacy as home of the first documented HIV cured patient, BeCURE is a research hub dedicated to advancing innovative strategies to cure HIV. “Something amazing is happening in Berlin”, said Jessica. “Christian Gaebler and his team, including Tomer Einav, are bringing cure to the people.”

Advancing the Vision for HIV Cure Research in Cameroon

AVAC attended an HIV cure agenda-setting workshop in Cameroon in May, building on discussions from 2025. Cameroon has emerged as a growing leader in HIV cure research in West Africa, fueled by significant recent investments in basic science and a rapidly expanding research landscape.

Hosted by the Cameroon government and supported by the African HIV Cure Consortium (AHCC), the workshop brought together the Ministry of Research, researchers, ethics experts and community members to identify immediate priorities and develop goals for advancing HIV cure research in the country over the next three to five years. The workshop helped lay the foundation for a coordinated national HIV cure strategy rooted in cross-sector collaboration and community engagement.

AVAC also supported Advocacy-For-A-Cure Academy Cure alumni Laurel Kelvine Tchanida to host a community forum alongside the workshop. The meeting focused on communication and advocacy strategies to tell the story of HIV cure and advance the scientific agenda.

What’s Next for HIV Cure: Insights from CROI 2026

HIV cure advocate and Advocacy-For-A-Cure Academy alumni Doreen Moraa spoke with some of the top HIV cure researchers at CROI 2026 to discuss takeaways from the conference, what’s next for HIV cure and what HIV cure means to them. In her latest video, Dr. Katie Barr unpacks the science and emphasizes the need for community to be at the center of it all. Doreen’s four-part CROI 2026 video series can be found on her YouTube channel, I Am A Beautiful Story, which she uses to educate, empower and break the stigma surrounding HIV.

Resource Roundup

• New York Times article: A Single Infusion Could Suppress HIV for Years, Study Suggests
• Body Pro Article: Can Gene Therapy Control HIV? Steven Deeks, MD, Explains the Science—and the Caveats
• TAG webinar on June 16: INSIDE HIV CURE RESEARCH: What’s Working, What’s Emergent and What’s Next
• Series of Jojo video: Analytic Treatment Interruption (ATI)
• Podcast on the ethics of pediatric HIV cure research: 10 Minutes with JPIDS